Design and evaluation of D-α tocopheryl polyethylene glycol 1000 succinate emulsified poly-ϵ-caprolactone nanoparticles for protein/peptide drug delivery

References

• Estey T, Kang J, Schwendeman SP, Carpenter JF. (2006). BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems. J Pharm Sci, 95:1626–1639.
   PubMed Web of Science ®Google Scholar
• Dulal P. (2010). Protein or peptide drugs: applications, problems and solutions. Biotechnology Society of Nepal(BSN) E-Bulletin [Online], 2.
   Google Scholar
• Figg WD, Kruger EA, Price DK, Kim S, Dahut WD. (2002). Inhibition of angiogenesis: treatment options for patients with metastatic prostate cancer. Invest New Drugs, 20:183–194.
   PubMed Web of Science ®Google Scholar
• Froidevaux S, Eberle AN. (2002). Somatostatin analogs and radiopeptides in cancer therapy. Biopolymers, 66:161–183.
   PubMed Web of Science ®Google Scholar
• Kerbel R, Folkman J. (2002). Clinical translation of angiogenesis inhibitors. Nat Rev Cancer, 2:727–739.
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Lukyanov AN. (2003). Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discov Today, 8:259–266.
   PubMed Web of Science ®Google Scholar
• Feng L, Qi XR, Zhou XJ, Maitani Y, Wang SC, Jiang Y et al. (2006). Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. J Control Release, 112:35–42.
   PubMed Web of Science ®Google Scholar
• Moioli EK, Hong L, Guardado J, Clark PA, Mao JJ. (2006). Sustained release of TGFbeta3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cells. Tissue Eng, 12:537–546.
   PubMedGoogle Scholar
• Orive G, Tam SK, Pedraz JL, Hallé JP. (2006). Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy. Biomaterials, 27:3691–3700.
   PubMed Web of Science ®Google Scholar
• Alexis F, Pridgen E, Molnar LK, Farokhzad OC. (2008). Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm, 5:505–515.
   PubMed Web of Science ®Google Scholar
• Benoit MA, Baras B, Gillard J. (1999). Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery. Int J Pharm, 184:73–84.
   PubMed Web of Science ®Google Scholar
• Attivi D, Wehrle P, Ubrich N, Damge C, Hoffman M, Maincent P. (2005). Formulation of insulin-loaded polymeric nanoparticles using response surface methodology. Drug Dev Ind Pharm, 31:179–189.
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. (2002). Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). J Control Release, 80:129–144.
   PubMed Web of Science ®Google Scholar
• Wempe MF, Wright C, Little JL, Lightner JW, Large SE, Caflisch GB et al. (2009). Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS. Int J Pharm, 370:93–102.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Feng SS. (2006). Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials, 27:262–270.
   PubMed Web of Science ®Google Scholar
• Mukerjee A, Sinha VR, Pruthi V. (2007). Preparation and characterization of poly-ϵ-caprolactone particles for controlled insulin delivery. J Biomed Pharm Eng 1:40–44.
   Google Scholar
• Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. (2004). Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm, 278:1–23.
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Ubrich N, Hombreiro Pérez M, Lehr C, Hoffman M, Maincent P. (2000). Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int J Pharm, 196:177–182.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tan S, Feng SS. (2012). Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials, 33:4889–4906.
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kulkarni SA, Xiong J, Feng SS. (2011). Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm, 421:332–340.
   PubMed Web of Science ®Google Scholar
• Mohanraj VJ, Chen Y. (2006). Nanoparticles-A Review. Tropical journal of Pharmaceutical Research, 5:561–573.
   Google Scholar
• Pathak P, Nagarsenker M. (2009). Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery. AAPS PharmSciTech, 10:985–992.
   PubMed Web of Science ®Google Scholar
• Abdelwahed W, Degobert G, Stainmesse S, Fessi H. (2006). Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev, 58:1688–1713.
   PubMed Web of Science ®Google Scholar
• Lince F, Marchisio DL, Barresi AA. (2008). Strategies to control the particle size distribution of poly-epsilon-caprolactone nanoparticles for pharmaceutical applications. J Colloid Interface Sci, 322:505–515.
   PubMed Web of Science ®Google Scholar
• Lee SH, Zhang Z, Feng SS. (2007). Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery. Biomaterials, 28:2041–2050.
   PubMed Web of Science ®Google Scholar
• Youan BB, Benoit MA, Baras B, Gillard J. (1999). Protein-loaded poly(epsilon-caprolactone) microparticles. I. Optimization of the preparation by (water-in-oil)-in water emulsion solvent evaporation. J Microencapsul, 16:587–599.
   PubMed Web of Science ®Google Scholar
• Blanco MD, Bernardo MV, Sastre RL, Olmo R, Muñiz E, Teijón JM. (2003). Preparation of bupivacaine-loaded poly(epsilon-caprolactone) microspheres by spray drying: drug release studies and biocompatibility. Eur J Pharm Biopharm, 55:229–236.
   PubMed Web of Science ®Google Scholar
• Gibaud S, Jabir Al Awwadi N, Ducki C, Astier A. (2004). Poly(epsilon-caprolactone) and Eudragit microparticles containing fludrocortisone acetate. Int J Pharm, 269:491–508.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang Y, Wei K, Zhao N, Zhang S, Chen J. (2009). Drug distribution within poly(ε-caprolactone) microspheres and in vitro release. J Mater Process Technol, 209:348–354.
   Web of Science ®Google Scholar
• Delie F, Blanco-Príeto MJ. (2005). Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules, 10:65–80.
   PubMed Web of Science ®Google Scholar
• Win KY, Feng SS. (2005). Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials, 26:2713–2722.
   PubMed Web of Science ®Google Scholar
• Kim BS, Oh JM, Kim KS, Seo KS, Cho JS, Khang G et al. (2009). BSA–FITC-loaded microcapsules for in vivo delivery. Biomaterials, 30:902–909.
   PubMed Web of Science ®Google Scholar